News

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
Moderna's RSV shot, mRESVIA, was the first non-COVID ... Sign up here. While the FDA approval is a necessary step, the U.S. Centers for Disease Control and Prevention still has to recommend ...
“RSV poses a serious health risk ... Kennedy Jr. A number lambasted Kennedy and the FDA on social media recently when the regulatory agency approved Moderna’s second-generation Covid-19 ...
Moderna may sell the shot for adults under 60 who are at increased risk from respiratory syncytial virus, or RSV, the company said in a statement. The Food and Drug Administration approved it last ...